About: Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 June 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в червні 2009 (uk) scientific article published on 30 June 2009 (en) مقالة علمية نشرت في 30 يونيو 2009 (ar)
publication date	wds:Q37536874-34486651-4FF2-4B89-AE25-13438033725A
publication date	2009-06-30 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37536874-99746F68-9CC3-4EEE-BFF5-AC5E2D476370
language of work or name	English
exact match	wds:Q37536874-CA9FACBB-C6EF-41CC-A7F7-4D5C9B9DC940
exact match	https://scigraph.springernature.com/pub.10.1038/ajg.2009.346
cites work	wds:Q37536874-09C4FC15-D249-4B17-9306-96C94B70C011 wds:Q37536874-0A1F4057-8598-4306-9208-C42E1BB912A1 wds:Q37536874-0EE4C11A-B94A-464C-A726-02237902F64D wds:Q37536874-10FCB184-9E0F-44B0-96AC-69D2F493CC42 wds:Q37536874-18DEFF64-1109-4EFC-A631-E0EC15865A1C wds:Q37536874-1D169775-9753-4156-A975-47260B43E226 wds:Q37536874-31BB984F-C6E6-4E40-A118-982B371901EC wds:Q37536874-3F1BFBC7-5152-40CF-99A4-72D7951695B4 wds:Q37536874-49254918-798F-4CA2-B635-2DFD0C1BCFA7 wds:Q37536874-4D8CA612-0290-430A-8963-3F76F9C0E36B wds:Q37536874-54A889E2-5E36-4B0A-8FC7-6DB292BBBF3F wds:Q37536874-5F072436-E0FE-41F0-BF7B-10328482B424 wds:Q37536874-60C1F865-0F94-4BCE-B853-C112584BB64A wds:Q37536874-70A2C2E9-C2FF-4980-800F-50F350449690 wds:Q37536874-74D3A520-CEB8-4C83-BB89-0B7623294502 wds:Q37536874-85F92F06-9CE7-4A64-873C-3F204ABD7FF3 wds:Q37536874-89050E14-306B-4CD2-98E1-19E46E8007AF wds:Q37536874-8A3B9CAC-6858-42E5-ACA4-B2823E2A2FA2 wds:Q37536874-98EF8F0D-F85D-424E-A9A0-92F6C339ECD3 wds:Q37536874-9D55DC66-AFEF-4750-B359-FEC720194516 wds:Q37536874-BECDBA04-E35E-4E14-AB8F-0637232B113E wds:Q37536874-C63D2D7E-B1AE-4FAD-97AB-0AFBC486D066 wds:Q37536874-C98FF421-9A58-440C-AE9D-651EF72977BD wds:Q37536874-D284B873-1978-4738-850B-8086176DA495 wds:Q37536874-D4EBC1DC-293E-45FD-9A86-EBACDBFA96BC wds:Q37536874-D7E2B00A-1D00-41C2-BDC0-2ACC17AB4552 wds:Q37536874-DEE7CC6E-A68F-4A25-A0BD-A1A6F0E39D64 wds:Q37536874-EFC875DC-0218-4E1F-953C-C7FF80BAC8E3 wds:Q37536874-FB77B437-F042-4AEE-9FFB-D806E1836102
cites work	The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement Utility approach to measuring health-related quality of life The estimation of a preference-based measure of health from the SF-36. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Improved cognitive function as a consequence of hepatitis C virus treatment Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study A new method of classifying prognostic comorbidity in longitudinal studies: development and validation The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C. The impact of diagnosis of hepatitis C virus on quality of life. Health-State Utilities and Quality of Life in Hepatitis C Patients Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Multi-attribute health status classification systems. Health Utilities Index Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Social stigmatization and hepatitis C virus infection "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C. Modelling SF-6D health state preference data using a nonparametric Bayesian method Assessment of cognitive status in the elderly using telephone interviews. Validity of the Telephone Interview for Cognitive Status (TICS) in post-stroke subjects. Estimation of utilities for chronic hepatitis C from SF-36 scores Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment.
author name string	wds:Q37536874-7E0BF196-A277-4B37-9AE2-E975E4E545A6 wds:Q37536874-88402FD8-8DF2-4E28-BFED-BE8B288F2796 wds:Q37536874-88CE58C3-45B5-4D07-BE8F-60DF0C8E4B49 wds:Q37536874-EA6FA9EA-4ECD-4C4E-A6B4-766D246346AB
author name string	E Jenny Heathcote Eric M Yoshida Ava A John-Baptiste Frank H Anderson
rdfs:label	Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (en) Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (nl) Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (ast)
skos:prefLabel	Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (en) Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (nl) Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (ast)
name	Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (en) Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (nl) Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. (ast)
author	wds:Q37536874-00F684BA-8120-465E-8BEA-DE0E7D419E8C wds:Q37536874-1D922F89-A9EC-4177-A654-38E3104F4C16

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software